Theodore Gouliouris
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 11
- Clinical Biochemistry top 0.5%
- Bacterial Identification and Susceptibility Testing 20
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 19
- Clostridium difficile and Clostridium perfringens research 6
- Endocrinology top 5%
- Escherichia coli research studies 4
-
- Nosocomial Infections in ICU 6
-
- Streptococcal Infections and Treatments 5
-
- COVID-19 and healthcare impacts 4
Theodore Gouliouris
50 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Medicine 492
- Applied Microbiology and Biotechnology 150
- Clinical Biochemistry 486
- Infectious Diseases 776
- Endocrinology 166
Countries citing papers authored by Theodore Gouliouris
This map shows the geographic impact of Theodore Gouliouris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore Gouliouris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore Gouliouris more than expected).
Fields of papers citing papers by Theodore Gouliouris
This network shows the impact of papers produced by Theodore Gouliouris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore Gouliouris. The network helps show where Theodore Gouliouris may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Theodore Gouliouris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 14 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 26 | |
| 13 | 2022 | 0 | |
| 14 | 2022 | 2 | |
| 15 | 2021 | 43 | |
| 16 | 2019 | 132 | |
| 17 | 2019 | 44 | |
| 18 | 2014 | 20 | |
| 19 | 2013 | 44 | |
| 20 | 2011 | 17 |
About Theodore Gouliouris
Theodore Gouliouris is a scholar working on Clinical Biochemistry, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 52 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (20 papers), Antimicrobial Resistance in Staphylococcus (19 papers), Antibiotic Resistance in Bacteria (11 papers), Nosocomial Infections in ICU (6 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Streptococcal Infections and Treatments (5 papers), Escherichia coli research studies (4 papers) and COVID-19 and healthcare impacts (4 papers). The work is most often cited by research in Molecular Medicine (492 citations), Applied Microbiology and Biotechnology (150 citations) and Clinical Biochemistry (486 citations). Theodore Gouliouris has collaborated with scholars based in United Kingdom, Thailand and Australia. Frequent co-authors include Nicholas M. Brown, Sani Aliyu, Sharon J. Peacock, Julian Parkhill, Kathy E. Raven, M. Estée Török, Beth Blane, Catherine Ludden, Plamena Naydenova and Francesc Coll.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.